Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis
Condition(s):Inherited Retinal Dystrophy Due to RPE65 Mutations; Leber Congenital AmaurosisLast Updated:February 23, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Inherited Retinal Dystrophy Due to RPE65 Mutations; Leber Congenital AmaurosisLast Updated:February 23, 2023Active, not recruiting
Condition(s):Leber Congenital AmaurosisLast Updated:April 10, 2018Completed
Condition(s):Leber Congenital Amaurosis; LCA; LCA1Last Updated:February 20, 2024Active, not recruiting
Condition(s):LCA (Leber Congenital Amaurosis); RP (Retinitis Pigmentosa)Last Updated:July 28, 2014Completed
Condition(s):LCA (Leber Congenital Amaurosis); RP (Retinitis Pigmentosa)Last Updated:May 14, 2013Completed
Condition(s):Leber Congenital Amaurosis, Retinitis PigmentosaLast Updated:August 9, 2018Unknown status
Condition(s):Leber Congenital AmaurosisLast Updated:October 7, 2015Completed
Condition(s):Leber Congenital Amaurosis 2; Retinitis Pigmentosa 20Last Updated:November 29, 2023Completed
Condition(s):Retinal DegenerationLast Updated:December 7, 2015Completed
Condition(s):Leber Congenital Amaurosis (LCA); Eye Diseases; Eye Diseases, Hereditary; Retinal DiseasesLast Updated:August 14, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.